Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Diagnostic and Prognostic Role of Plasma Biomarkers in Alzheimer's Disease

NCT07717567 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT07717567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07717567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Diagnostic and Prognostic Role of Plasma Biomarkers in Alzheimer's Disease
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
September 12, 2023
Completion date
June 1, 2032
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive impairment, dementia, mild cognitive impairment, subjective cognitive decline